Business Intelligence on Biologic and Small Molecule Drugs
Chart 1 – Clear inflexion point at Candidate Identification
Chart 1. Within the R&D process there is a clear inflexion point at Candidate Identification (CI) with a marked differentiation between the iterative ‘design-test-analyze’ learning cycles that define the pre-CI discovery phases and the linear and sequential ‘protocol-driven’ development activities that occur after CI.